Hoya Corp (HOCPY)
114.06
+2.50
(+2.24%)
USD |
OTCM |
Apr 22, 16:00
Hoya Enterprise Value: 36.78B for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 36.78B |
| April 19, 2024 | 35.91B |
| April 18, 2024 | 36.65B |
| April 17, 2024 | 36.54B |
| April 16, 2024 | 36.36B |
| April 15, 2024 | 35.45B |
| April 12, 2024 | 34.93B |
| April 11, 2024 | 35.81B |
| April 10, 2024 | 35.70B |
| April 09, 2024 | 37.07B |
| April 08, 2024 | 37.30B |
| April 05, 2024 | 37.39B |
| April 04, 2024 | 38.87B |
| April 03, 2024 | 39.29B |
| April 02, 2024 | 39.67B |
| April 01, 2024 | 40.38B |
| March 28, 2024 | 40.46B |
| March 27, 2024 | 40.66B |
| March 26, 2024 | 41.22B |
| March 25, 2024 | 41.00B |
| March 22, 2024 | 42.30B |
| March 21, 2024 | 43.09B |
| March 20, 2024 | 42.88B |
| March 19, 2024 | 42.17B |
| March 18, 2024 | 42.37B |
| Date | Value |
|---|---|
| March 15, 2024 | 41.89B |
| March 14, 2024 | 41.03B |
| March 13, 2024 | 41.46B |
| March 12, 2024 | 42.12B |
| March 11, 2024 | 42.12B |
| March 08, 2024 | 43.24B |
| March 07, 2024 | 43.69B |
| March 06, 2024 | 43.23B |
| March 05, 2024 | 42.71B |
| March 04, 2024 | 42.78B |
| March 01, 2024 | 43.76B |
| February 29, 2024 | 42.41B |
| February 28, 2024 | 40.94B |
| February 27, 2024 | 41.38B |
| February 26, 2024 | 42.19B |
| February 23, 2024 | 41.19B |
| February 22, 2024 | 41.25B |
| February 21, 2024 | 39.84B |
| February 20, 2024 | 39.93B |
| February 16, 2024 | 40.37B |
| February 15, 2024 | 40.26B |
| February 14, 2024 | 39.62B |
| February 13, 2024 | 39.29B |
| February 12, 2024 | 39.65B |
| February 09, 2024 | 39.21B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.07B
Minimum
Apr 23 2019
61.10B
Maximum
Sep 14 2021
37.17B
Average
35.26B
Median
Aug 24 2022
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 72.75B |
| Nxera Pharma Co Ltd | 1.010B |
| PeptiDream Inc | 1.250B |
| Stemcell Holdings Inc | -- |
| Healios KK | 68.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 264.03M |
| Revenue (Quarterly) | 1.359B |
| Total Expenses (Quarterly) | 605.80M |
| EPS Diluted (Quarterly) | 0.7465 |
| Gross Profit Margin (Quarterly) | 87.10% |
| Profit Margin (Quarterly) | 19.43% |
| Earnings Yield | 2.95% |
| Operating Earnings Yield | 7.49% |
| Normalized Earnings Yield | 3.081 |